-

Winter ‘25

Learn about how collaboration leads to discovery in the winter edition of Illuminate.

From the director

At WEHI, we are motivated by a clear purpose: to make scientific discoveries and transform them into better health outcomes.

The National Drug Discovery Centre (NDDC) is playing a critical role in this journey. Streamlining the drug development process, it allows us to test hundreds of thousands
of compounds against new disease targets in rapid time.

The NDDC helps take brilliant ideas where they need to go: to the patient in the clinic.

Headquartered at WEHI and established with vital government and philanthropic support, it is changing how discoveries are translated into potential treatments.

As the nation’s premier small molecule drug screening facility, the NDDC provides researchers from across Australia with access to cutting-edge technologies that would otherwise only be available in major pharmaceutical companies. By working together, we are boosting the national capacity for therapeutic innovation.

 

 

In this edition we share two excellent examples of the NDDC speeding up drug discovery. Read ‘Brighter Together’ (page 4) to learn about the development of the first potential treatment for a rare neurological condition. And our feature story (page 6) highlights a critical advance in research working towards the first treatment for long COVID.

The NDDC is driving focused, fast and deeply collaborative translational science. I look forward to bringing you more on the discoveries it is helping to accelerate.

WEHI Director, Professor Ken Smith AO

 

Scientists in the National Drug Discovery Centre

Are you interested in supporting our research?

Your support will help WEHI’s researchers make discoveries and find treatments to ensure healthier, longer lives for you and your loved ones.

Previous editions 

View all editions
Sign up to our quarterly newsletter Illuminate

Find out about recent discoveries, community supporters and more.

Illuminate Winter 2025
View the current issue